UK dairy farmers are planning to market the controversial A2 milk, said to be better for the heart, and also claimed to help children with autism.
A2 milk derives its name from the type of protein contained in the milk - most of the milk sold in the UK contains more A1 which some researchers have claimed could increase the risk of heart disease.
Currently available in New Zealand and Australia, producers in the UK are preparing to offer milk which does not contain the A1 proteins, according to a BBC report. Only a few herds in the UK produce the A2 milk but companies are expecting high demand, it said.
Research showing the link between A1 milk and heart disease is so far preliminary but the issue has caused much debate in New Zealand.
Some scientists believe that high rates of cardiovascular disease in certain regions of the UK could be connected to the type of milk produced in those areas.
The New Zealand-based A2 Corporation, founded to promote milk that contains only the A2 variety of beta casein protein, launched the A2 milk brand on the home market and in Australia in April. Recent reports suggest that the firm is looking to license its technology to overseas markets.
The firm is currently in a court battle with major dairy group Fonterra, which it claims suppressed research linking milk containing the A1 protein to autism, schizophrenia, diabetes and heart disease.
Fonterra has denied the claims and Food Standards Australia and New Zealand (FSANZ) continues to advise milk is a safe and nutritious component of the diet for most people.